While early, the results indicate drugs known as ITK inhibitors have the potential to match or surpass the efficacy observed with the injectable biologic Dupixent.
Corvus Pharmaceuticals soars on promising Phase 1 data for soquelitinib. But CRVS shares may not be able to sustain today's ...
The sizzle is the excitement about the hunt for the next big blockbuster, and the only one that anyone sees on the horizon is ...
For Tracy Owen, eczema was much more than dry skin. It came to dictate every aspect of her life, from relationships to how she dressed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results